share_log

Establishment Labs Holdings' (NASDAQ:ESTA) Growing Losses Don't Faze Investors as the Stock Rises 4.5% This Past Week

Establishment Labs Holdings' (NASDAQ:ESTA) Growing Losses Don't Faze Investors as the Stock Rises 4.5% This Past Week

納斯達克股票代碼ESTA公司的日益增長的虧損並未讓投資者感到擔心,股票在過去一週上漲了4.5%。
Simply Wall St ·  09/16 19:47

The most you can lose on any stock (assuming you don't use leverage) is 100% of your money. But on the bright side, if you buy shares in a high quality company at the right price, you can gain well over 100%. Long term Establishment Labs Holdings Inc. (NASDAQ:ESTA) shareholders would be well aware of this, since the stock is up 121% in five years. Meanwhile the share price is 4.5% higher than it was a week ago.

任何一隻股票的最大虧損(假設您沒有使用槓桿)是您的資金的100%。但好的一面是,如果您以合適的價格購買高質量的公司股票,您的收益可能會大於100%。長揸納斯達克(NASDAQ)上市的Establishment Labs Holdings股份(ESTA)的股東對此應該非常清楚,因爲該股票在五年內上漲了121%。同時,股價較一週前高出4.5%。

On the back of a solid 7-day performance, let's check what role the company's fundamentals have played in driving long term shareholder returns.

在穩定的七天表現之後,讓我們看看公司的基本面對長期股東回報的影響。

Given that Establishment Labs Holdings didn't make a profit in the last twelve months, we'll focus on revenue growth to form a quick view of its business development. Shareholders of unprofitable companies usually desire strong revenue growth. That's because it's hard to be confident a company will be sustainable if revenue growth is negligible, and it never makes a profit.

鑑於Establishment Labs Holdings在過去的十二個月裏沒有盈利,我們將重點關注其營業收入的增長,以快速了解其業務發展情況。通常,無利潤公司的股東希望看到強勁的營業收入增長。這是因爲如果營業收入增長微不足道,且公司從未盈利,很難對其可持續性感到有信心。

In the last 5 years Establishment Labs Holdings saw its revenue grow at 17% per year. Even measured against other revenue-focussed companies, that's a good result. Meanwhile, its share price performance certainly reflects the strong growth, given the share price grew at 17% per year, compound, during the period. This suggests the market has well and truly recognized the progress the business has made. To our minds that makes Establishment Labs Holdings worth investigating - it may have its best days ahead.

在過去的五年裏,Establishment Labs Holdings的營業收入每年增長17%。即使與其他以營收爲重點的公司相比較,這也是一個不錯的結果。與此同時,其股價表現確實反映了強勁的增長,因爲股價在這段時間內以每年17%的複合增長。這表明市場已經充分認識到該業務取得的進展。據我們所知,這使得Establishment Labs Holdings值得進一步調查-它的未來或許會更好。

The graphic below depicts how earnings and revenue have changed over time (unveil the exact values by clicking on the image).

下面的圖表顯示了收益和營收隨時間的變化情況(通過單擊圖像揭示確切的值)。

big
NasdaqCM:ESTA Earnings and Revenue Growth September 16th 2024
NasdaqCM:ESTA收益和營業收入增長於2024年9月16日

We consider it positive that insiders have made significant purchases in the last year. Even so, future earnings will be far more important to whether current shareholders make money. So we recommend checking out this free report showing consensus forecasts

我們認爲內部人士在過去一年中進行了重大購買是一個積極因素。即便如此,未來的收益對於現有股東賺錢是否更重要,因此我們建議查看這份顯示共識預測的免費報告。

A Different Perspective

不同的觀點

Establishment Labs Holdings shareholders are down 15% for the year, but the market itself is up 26%. Even the share prices of good stocks drop sometimes, but we want to see improvements in the fundamental metrics of a business, before getting too interested. On the bright side, long term shareholders have made money, with a gain of 17% per year over half a decade. It could be that the recent sell-off is an opportunity, so it may be worth checking the fundamental data for signs of a long term growth trend. I find it very interesting to look at share price over the long term as a proxy for business performance. But to truly gain insight, we need to consider other information, too. Even so, be aware that Establishment Labs Holdings is showing 2 warning signs in our investment analysis , you should know about...

成立實驗室控股有限公司股東今年虧損15%,但市場本身上漲了26%。即使好股票的股價有時也會下跌,但在我們對業務的基本指標有所改善之前,我們希望看到一些進展。

Establishment Labs Holdings is not the only stock insiders are buying. So take a peek at this free list of small cap companies at attractive valuations which insiders have been buying.

成立實驗室控股公司並不是唯一一個內部人士正在購買的股票。所以,請查看這份免費的小盤公司名單,這些公司以有吸引力的估值被內部人士購買。

Please note, the market returns quoted in this article reflect the market weighted average returns of stocks that currently trade on American exchanges.

請注意,本文所引述的市場回報反映了目前在美國交易所上市的股票的市場加權平均回報。

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

對本文有任何反饋?對內容有任何疑慮?請直接與我們聯繫。或者,發送電子郵件至editorial-team@simplywallst.com。
這篇文章是Simply Wall St的一般性文章。我們根據歷史數據和分析師預測提供評論,只使用公正的方法論,我們的文章並不意味着提供任何金融建議。文章不構成買賣任何股票的建議,也不考慮您的目標或您的財務狀況。我們的目標是帶給您基本數據驅動的長期關注分析。請注意,我們的分析可能不考慮最新的價格敏感公司公告或定性材料。Simply Wall St沒有任何股票頭寸。

譯文內容由第三人軟體翻譯。


以上內容僅用作資訊或教育之目的,不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。
    搶先評論